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Abstract 
Rationale and Objectives: To determine the impact of additional coronary-calcium-
scoring on total effective radiation dose and diagnostic accuracy of low-dose 
computed tomography coronary angiography (CTCA) with prospective 
electrocardiogram (ECG)-triggering.   
Materials and Methods: Sixty-one consecutive patients underwent 64-slice CTCA 
using prospective ECG-triggering, calcium-scoring and invasive quantitative coronary 
angiography (QCA), the latter served as standard of reference. Diagnostic accuracy 
was calculated for CTCA, calcium scoring and for the combination of both. Receiver 
operator characteristic analyses were performed to determine cut-offs for prediction 
of significant coronary artery stenoses. 
Results: Mean effective radiation dose was 2.10.7mSv (range 1.0-3.3mSv) for 
CTCA and 1.10.1mSv (range 0.9-1.4mSv) for calcium-scoring. Per-patient 
sensitivity, specificity, positive predictive value (PPV), and negative predictive value 
were 100%, 85.7%, 89.2%, and 100% for CTCA, and 72.7%, 82.1%, 82.8%, and 
71.9% for calcium-scoring. Adding calcium-scoring with a cut-off at 133 in patients 
aged >50.7 years with non-diagnostic CTCA improved the respective values of 
diagnostic accuracy of the entire study population to 100%, 96.4%, 97.1%, and 
100%; the added value of calcium-scoring was confined to only 3 patients (5%), who 
were reclassified from false positive to true negative. 
Conclusion: Specificity and PPV of low-dose CTCA may be further improved by 
combining it with coronary-calcium-scoring. However, only a fraction of patient may 
benefit, while exposing the entire population to more than 50% increase in effective 
radiation dose.  
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Introduction 
Computed tomography coronary angiography (CTCA) with prospective 
electrocardiogram (ECG)-triggering has recently been introduced and shown to offer 
a tremendous reduction of radiation dose compared to retrospective ECG-gating (1-
6). Hence, a widespread clinical acceptance of non-invasive imaging of the coronary 
arteries with CTCA may now be envisioned. In selected patient populations with low 
heart rates, initial reports have demonstrated a high diagnostic accuracy of low dose 
CTCA with prospective ECG-triggering compared to the current reference standard 
quantitative coronary angiography (QCA) (7-9), similar to the diagnostic accuracy 
achieved by retrospective ECG-gating technique (8).  
However, the occurrence of artefacts leading to non-diagnostic image quality 
has been described (2-5, 7-10). When artefacts render CTCA image quality non-
diagnostic, patient examinations in clinical routine should be considered as positive 
and patients should be referred to further clinical work-up, i.e. proof of stress-induced 
ischemia and/or invasive coronary angiography (ICA). Therefore, depending on the 
occurrence rate of non-diagnostic image quality, a considerable number of patients 
will unnecessarily undergo ICA, due to false positive CTCA findings.  
The additional use of coronary calcium-scoring has been described to improve 
diagnostic accuracy of CTCA with retrospective ECG-gating (11-14), especially when 
used to determine the presence of CAD only in patients with non-diagnostic image 
quality in CTCA. However, in CTCA with prospective ECG-gating the effective 
radiation dose has been reduced so much, that the radiation dose of CTCA (in 
patients with low body mass index) can occasionally equal the radiation dose of a 
coronary calcium score (15), rendering the usefulness of an additional calcium score 
questionable.  
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Therefore, it was the purpose of this study to determine the impact of 
additional coronary calcium-scoring on total effective radiation dose and diagnostic 
accuracy of low-dose CTCA with prospective ECG-triggering.   
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Materials and Methods 
Sixty-one consecutive patients with known or suspected CAD scheduled for 
QCA were prospectively enrolled and underwent an additional CTCA if none of the 
following exclusion criteria were present: previous stent placement, previous 
coronary bypass surgery, hypersensitivity to iodinated contrast agent, renal 
insufficiency (creatinine levels >150 µmol/L, or >1.7mg/dl), non-sinus rhythm, acute 
coronary syndrome, heart rates >80 bpm providing there were no contraindications 
for beta-blocker medication, or heart rates >65 bpm when beta-blocker medication 
was not feasible. Patients were referred because of dyspnoe (n=12), typical angina 
pectoris (n=35), atypical chest pain (n=11) or because of elevated coronary risk 
factors (n=3). 
The study protocol was approved by the institutional review board and written 
informed consent was obtained from all patients. 
 
All CT examinations were performed on a LightSpeed VCT XT scanner (GE 
Healthcare). All patients received a single dose of 2.5 mg isosorbiddinitrate 
sublingual (Isoket, Schwarz Pharma, Monheim, Germany) 2 min prior to the CTCA 
scanning. In addition, intravenous metoprolol (5 to 20 mg) (Beloc, AstraZeneca, 
London, UK) was administered prior to the CTCA examination if necessary to 
achieve a target heart rate <65 bpm.  
Coronary calcium scoring was performed with the following scanning 
parameters: prospective ECG-triggering, 2.5 mm slice thickness, 120 kV tube voltage, 
200 mA tube current, and large scan field-of-view of 50 x 50 cm. For CTCA, 80 ml of 
iodixanol (Visipaque 320, 320 mg/mL, GE Heathcare, Buckinghamshire, UK) at a 
flow rate of 5 mL/s (1.6 g iodine/sec) followed by 50 ml saline solution was injected 
into an antecubital vein via an 18-gauge catheter. CTCA was performed with 
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prospective ECG-triggering (SnapShot Pulse, GE Healthcare) and the following 
scanning parameters: bolus tracking in the ascending aorta, collimation 64 × 0.625 
mm, smallest x-ray window (only 75% of the RR-cycle), z-coverage 40 mm with an 
increment of 35 mm, gantry rotation time 350 ms, temporal resolution 175 ms, body 
mass index (BMI) adapted tube voltage (100kV:  BMI <25kg/m2, 120 kV: BMI 
≥25kg/m2)  and current (450mA: BMI <22.5kg/m2, 500mA: BMI 22.5-25kg/m2 , 
550mA: BMI 25-27.5kg/m2, 600mA: BMI 27.5-30kg/m2, 650mA: BMI 30-40kg/m2, 
700mA: BMI >40kg/m2). Scanning was performed with a small scan field-of-view of 
32 x 32 cm from below the tracheal bifurcation to the diaphragm, choosing 3 to 5 
scan blocks (z-coverage 11 to 18 cm). By choosing the smallest possible window at 
only one distinct enddiastolic phase of the RR-cycle (i.e. centered at 75%) we 
ascertained the lowest achievable effective dose delivery, the effective dose of CTCA 
was calculated as the product of the dose-length product (DLP) times a conversion 
coefficient for the chest (k = 0.017 mSv/mGy x cm) as previously suggested (16). All 
images were transferred to an external workstation (AW 4.4, GE Healthcare).  
 
Two independent readers assessed image quality in all coronary segments as 
“diagnostic” or “non-diagnostic”, for any disagreement in data analysis between the 
two observers, consensus agreement was achieved. 
For analysis of CTCA data, coronary arteries were segmented as suggested 
by the American Heart Association (17): The right coronary artery (RCA) was defined 
to include segments 1-4, the left main artery (LM) and the left anterior descending 
artery (LAD) to include segments 5-10, and the left circumflex artery (CX) to include 
segments 11-15. The intermedial artery was designated as segment 16, if present. 
All segments with a diameter of at least 1.5 mm at their origin were included.  
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Images were evaluated and classified by two independent readers using axial 
source images, multi-planar reformations, and thin-slab maximum intensity 
projections on a per-vessel and per-patient basis. Both readers visually assessed all 
coronary artery segments for the presence of significant stenoses, defined as 
narrowing of the coronary luminal diameter ≥50%. Diagnostic accuracy of CTCA was 
determined on an “intention-to-diagnose”-basis; no coronary segment was excluded; 
non-evaluative segments were rated as stenosed, as previously suggested (18). 
 
QCA was performed according to standard techniques, and multiple views 
were stored on a CD-ROM. The angiograms were quantitatively evaluated using 
QCA software (Xcelera, PhilipsMedical Systems, the Netherlands) by an independent 
and experienced interventional cardiologist blinded to the results from CT coronary 
angiography. Coronary artery segments were defined as mentioned above (17), and 
analysis was performed in all vessels with a luminal diameter of at least 1.5 mm, 
excluding those vessels distal to complete occlusions. Each vessel segment was 
scored as being significantly stenosed, defined as a diameter reduction of ≥ 50%.  
 
Quantitative variables were expressed as mean ± standard deviation and 
categorical variables as frequencies, or percentages. Sensitivity, specificity, positive 
predictive value (PPV), and negative predictive value (NPV) were calculated; QCA 
was the standard of reference. The 95% confidence intervals (CI) were calculated 
from binomial expression per-vessel and per-patient, taking the clustered nature of 
the data into account (i.e. the 244 examined coronary vessel were not independent 
but clusters of vessels in 61 patients). Receiver operator characteristic (ROC) 
analyses were performed to determine patient- and vessel-based cut-offs for 
prediction of significant coronary artery stenoses (diameter reduction of ≥ 50%), and 
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to determine cut-offs for prediction of false negative findings. A P-value of <0.05 was 
considered to indicate statistical significance. SPSS software (SPSS 15.0, Chicago, 
ILL, USA) and Stata software (StataCorp 10.0, College Station, USA) were used for 
statistical testing.  
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Results 
CTCA was successfully performed in all 61 patients; demographics are given 
in Table 1. Sixteen of 61 patients (26%) were on beta blocker medication as part of 
their baseline medication; additional intravenous beta blockers were administered for 
heart rate control prior to CTCA in 35 patients (57%). The mean DLP from calcium-
scoring was 63.65.8 mGycm (range 54.8-82.0 mGycm) resulting in an estimated 
mean applied radiation dose of 1.10.1 mSv (range 0.9-1.4 mSv); respective values 
for CTCA were 126.042.2 mGycm (range 58.3-193.2 mGycm) and 2.10.7 mSv 
(range 1.0-3.3 mSv). 
The overall prevalence of CAD was 54% (33 of 61 patients). For CTCA, per-
patient sensitivity, specificity, PPV, and NPV were 100%, 85.7%, 89.2%, and 100%, 
while the respective vessel-based values were 93.1%, 85.5%, 72.8%, and 96.7% 
(Table 2). With receiver operator characteristic (ROC) curves cut-off calcium score 
values of 133 (patient-based) and 57 (vessel-based) were determined (P<0.001) for 
prediction of significant coronary artery stenoses (Figure 1). For these cut-off values 
the diagnostic accuracy of coronary calcium-scoring is given in Table 2.  
To determine the added value of combining CTCA with calcium-scoring, the 
latter was used to determine the presence of significant CAD only in patients with 
non-diagnostic CTCA image quality. With this approach patient-based specificity and 
PPV were improved (from 85.7% and 89.2% to 96.4% and 96.9%), while, sensitivity 
and NPV decreased (from 100% and 100% to 93.9% to 93.1%; Table 2).  
As significant coronary stenoses may be present especially in younger 
patients despite zero or low coronary calcium scores (19, 20), any added diagnostic 
value of calcium-scoring may be age dependent and mostly pronounced in advanced 
age. In fact, ROC analyses determined cut-off ages of 50.7 (P<0.05) for predicting 
false negative findings of combined CTCA and calcium-scoring. At this cut-off for the 
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combined analysis with calcium-score plus CTCA in patients over 51 years with non-
diagnostic CTCA image quality results in a per-patient sensitivity, specificity, PPV, 
and NPV of 100%, 96.4%, 97.1%, and 100% (Table 2). The cut-off age for the per-
vessel analysis turned out to be slightly higher, namely at >69 years (area under the 
curve: 0.91, P<0.01), resulting in similar accuracy values of 93%, 87%, 74%, and 
97% (Table 2). Notably, the added value of calcium-scoring was limited to only 3 
patients (5%), who were reclassified from false positive to true negative, while the 
mean effective radiation dose of the entire population increased by 52% (from 2.1 to 
3.2 mSv). 
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Discussion 
Low effective radiation dose and high diagnostic accuracy are the main 
determinants for successful implementation of CTCA in everyday clinical routine. 
Although CTCA scans with low effective radiation exposure are now feasible with 
prospective ECG-triggering, non-diagnostic image quality may occasionally still occur 
(2-5, 7-9) and potentially impair the clinical usefulness of CTCA. Coronary calcium-
scoring has been suggested as an adjunct to CTCA with retrospective ECG-gating 
(11-14), in order to determine the presence of CAD in patients with non-diagnostic 
image quality in CTCA. The present study shows that an additional coronary calcium-
score improves accuracy by increasing specificity and PPV of low-dose CTCA. 
However, the added value of calcium-scoring was limited to a small fraction of the 
patients, as only 5% were reclassified from false positive to true negative, at the cost 
of increasing the mean effective radiation dose of the entire population by 1.1 mSv 
(52%). 
It is important to notice, that the previously suggested cut-offs for the 
determination of significant CAD are within a range of 130 (11) and 400 (14), which 
might be caused by differences in the study populations, i.e. age (19, 20) and 
prevalence of CAD. In our study we found a relatively low prevalence of CAD and a 
relatively low mean age, most probably contributing to a rather low cut-off at 133.  
While the added value of coronary calcium score has been demonstrated with 
CTCA using retrospective ECG-gating, the present study confirms, that an additional 
calcium score may also improve the diagnostic accuracy of CTCA using prospective 
ECG-triggering. However, the latter scanning protocol results in a much lower 
effective radiation dose to the patient as compared to previous retrospective ECG-
gating. Therefore, the balance of harms and benefits of the additional radiation dose 
by calcium scoring needs to be reevaluated. In fact, the relative increase in total 
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effective radiation dose to all patients was substantial, to the benefit of only very few 
patients who were reclassified and in whom ICA would be avoidable. The balance 
may be favourably shifted to the benefits in patient populations with higher age and 
minor coronary calcifications (Figure 2).  
The usefulness of additional calcium scoring in low-dose CTCA may remain 
an issue of discussion in the next future, as with the introduction of faster CT scanner 
systems with larger detector widths encompassing the entire heart, (21) the 
occurrence of non-diagnostic CTCA image quality (caused by motion or stair-step 
artefacts) will most likely further decrease, potentially rendering additional coronary 
calcium scoring redundant. In fact, even with regard to prognosis CTCA may prove 
superior to coronary calcium-scoring (22). 
 
We acknowledge the following limitations to our study. The ROC curve-
determined cut-off ages for identifying false negative findings of combined CTCA and 
calcium-scoring are based on small numbers, therefore the cut-off value (though 
statistically significant) must be judged with caution and further studies are required 
to confirm our findings. As mentioned above, one should be cautious when trying to 
extrapolate our results to other populations with different demographics, especially 
age as well as coronary calcium load.  
 
In conclusion, low-dose CTCA with prospective ECG-triggering provides high 
diagnostic accuracy in the assessment of CAD. Specificity and PPV of low-dose 
CTCA may be further improved by combining it with coronary calcium-scoring. 
However, only a fraction of patient may benefit, while exposing the entire population 
to more than 50% increase in effective radiation dose. 
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Figure legends  
 
Figure 1:   
 Receiver operator characteristic (ROC) curve identifying the cut-off coronary 
calcium score for prediction of significant coronary artery stenoses (A, patient-based; 
B, vessel-based). AUC: area under the curve. 
 
Figure 2:   
CTCA images demonstrate normal left coronary arteries (A, B, C) but a severe 
motion artifact in the right coronary artery (arrow heads in E and F) rendering image 
quality non-diagnostic and the examination positive (intension-to-diagnose). Combing 
CTCA with coronary calcium score (i.e. 5) allowed to reclassify this 64-year-old 
patient to be free of coronary artery disease, which was confirmed by invasive 
coronary angiography (D and G). 
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Table 1.  Patient demographics 
Number of patients 61 
Age in years (mean  SD, range) 61  11, 30 - 85 
Female gender (n) 24 
Male gender (n) 37 
Body mass index in kg/m2 (mean  SD, range) 27  5, 19 - 45 
Heart rate in bpm (mean  SD, range) 56  7, 36 - 70 
Coronary risk factors (n) 
Smokers 
Hypertension 
Diabetes 
Positive family history 
Dyslipidemia 
 
28 
36 
4 
22 
28 
Calcium score (mean  SD, range) 481  885, 0 - 5477 
Calcium score percentiles (n) 
<25th percentile 
25-50th percentile 
50-75th percentile 
75-90th percentile 
>90th percentile 
 
17 
8 
10 
8 
18 
 
 
 
 
 
 
 
Table 2.  Diagnostic accuracy of CTCA, calcium scoring and of the combination of both 
 sensitivity             specificity PPV NPV 
CTCA: 
 100% (33/33; n.a.) 85.7% (24/28; 67.3-95.9) 89.2% (33/37; 74.6-96.9) 100% (24/24; n.a.) 
Calcium-Score: 
 72.7% (24/33; 54.5-86.7) 82.1% (23/28; 63.1-93.4) 82.8% (24/29; 64.2-94.2) 71.9% (23/32; 53.3-86.3) 
CTCA plus Calcium-Score: 
 93.9% (31/33; 79.8-99.3) 96.4% (27/28; 81.6-99.9) 96.9% (31/32; 83.8-99.9) 93.1% (27/29; 77.2-99.2) 
CTCA plus Calcium-Score, patients age >50.7 years: P
a
t
i
e
n
t
-
b
a
s
e
d
 
 
 100% (33/33; n.a.) 96.4% (27/28; 81.7-99.9) 97.1% (33/34; 84.7-99.9) 100% (27/27; n.a.) 
CTCA: 
 93.1% (67/72; 84.5-97.7) 85.5% (147/172; 79.3-90.4) 72.8% (67/92; 62.6-81.6) 96.7% (147/152; 92.5-98.9) 
Calcium-Score: 
 70.8% (51/72; 58.9-80.9) 83.7% (144/172; 77.3-88.9) 64.6% (51/79; 53.0-75.0) 87.3% (144/165; 81.2-91.6) 
CTCA plus Calcium-Score combined: 
 93.1% (67/72; 84.5-97.7) 92.4% (159/172; 87.4-95.9) 83.8% (67/80; 73.8-91.1) 96.9% (159/164; 93.0-99.0) 
CTCA plus Calcium-Score, patients age >68.8 years: V
e
s
s
e
l
-
b
a
s
e
d
 
 
 93.1% (67/72; 84.5-97.7) 86.6% (149/172; 80.6-91.3) 74.4% (67/90; 64.2-83.1) 96.8% (149/154; 92.6-98.9) 
 
Numbers in parenthesis correspond to the absolute values and the 95% confidence interval. PPV: positive predictive value. NPV: 
negative predictive value. NA: not available. 
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